CN113908110A - Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof - Google Patents
Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof Download PDFInfo
- Publication number
- CN113908110A CN113908110A CN202111453662.0A CN202111453662A CN113908110A CN 113908110 A CN113908110 A CN 113908110A CN 202111453662 A CN202111453662 A CN 202111453662A CN 113908110 A CN113908110 A CN 113908110A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- extract
- aging
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 70
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 78
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000003906 humectant Substances 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 17
- 235000020739 avocado extract Nutrition 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 12
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract description 7
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims description 26
- 238000010438 heat treatment Methods 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 21
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 12
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 11
- 108010087806 Carnosine Proteins 0.000 claims description 11
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 11
- 229940044199 carnosine Drugs 0.000 claims description 11
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 11
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 9
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 9
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 9
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 9
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 9
- 239000012467 final product Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 229940109850 royal jelly Drugs 0.000 claims description 9
- 229960003080 taurine Drugs 0.000 claims description 9
- 229930003799 tocopherol Natural products 0.000 claims description 9
- 235000010384 tocopherol Nutrition 0.000 claims description 9
- 229960001295 tocopherol Drugs 0.000 claims description 9
- 239000011732 tocopherol Substances 0.000 claims description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 8
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 8
- RGXYBFJDNNODFP-AWCRTANDSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-4-methylsulfonylbutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)N[C@@H](CCCCN)C(O)=O RGXYBFJDNNODFP-AWCRTANDSA-N 0.000 claims description 8
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 8
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 8
- 244000131316 Panax pseudoginseng Species 0.000 claims description 8
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 8
- -1 acetyl chitosamine Chemical compound 0.000 claims description 8
- 229940116229 borneol Drugs 0.000 claims description 8
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 8
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 8
- 229940075000 frankincense extract Drugs 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 8
- 102000016942 Elastin Human genes 0.000 claims description 6
- 108010014258 Elastin Proteins 0.000 claims description 6
- 229920002549 elastin Polymers 0.000 claims description 6
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 5
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 4
- 241000983746 Saccharina latissima Species 0.000 claims description 4
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims description 4
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims description 4
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 4
- 229940101267 panthenol Drugs 0.000 claims description 4
- 235000020957 pantothenol Nutrition 0.000 claims description 4
- 239000011619 pantothenol Substances 0.000 claims description 4
- 229940032094 squalane Drugs 0.000 claims description 4
- 244000061520 Angelica archangelica Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 229940064064 purslane extract Drugs 0.000 claims 1
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 61
- 230000032683 aging Effects 0.000 abstract description 21
- 230000003647 oxidation Effects 0.000 abstract description 8
- 238000007254 oxidation reaction Methods 0.000 abstract description 8
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 94
- 235000006708 antioxidants Nutrition 0.000 description 18
- 150000003254 radicals Chemical class 0.000 description 11
- 230000037303 wrinkles Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 241000382455 Angelica sinensis Species 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 description 3
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 244000234609 Portulaca oleracea Species 0.000 description 3
- 235000001855 Portulaca oleracea Nutrition 0.000 description 3
- 102100033220 Xanthine oxidase Human genes 0.000 description 3
- 108010093894 Xanthine oxidase Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000002085 irritant Substances 0.000 description 3
- 231100000021 irritant Toxicity 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 102000011727 Caspases Human genes 0.000 description 2
- 108010076667 Caspases Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 102000016387 Pancreatic elastase Human genes 0.000 description 2
- 108010067372 Pancreatic elastase Proteins 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 108010092464 Urate Oxidase Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 229940083957 1,2-butanediol Drugs 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002579 anti-swelling effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 150000001893 coumarin derivatives Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a periocular anti-aging traditional Chinese medicine skin care composition and a preparation method thereof, and relates to the field of skin care. The anti-aging traditional Chinese medicine skin care composition for the periphery of eyes comprises the following raw materials in parts by weight: 1.7-5.2 parts of traditional Chinese medicinal materials, 0.1-0.5 part of avocado extract, 0.1-0.3 part of glabrous greenbrier rhizome extract, 2-6 parts of humectant, 1-3 parts of anti-aging agent, 0.5-2 parts of antioxidant and 60-80 parts of water. The traditional Chinese medicine composition is added with various traditional Chinese medicine extracts, can mildly maintain skin, has the effects of resisting oxidation and aging and eliminating black eyes, and has excellent effect due to the synergistic effect of various traditional Chinese medicine components.
Description
Technical Field
The invention relates to the field of skin care, and particularly relates to a periocular anti-aging traditional Chinese medicine skin care composition and a preparation method thereof.
Background
The skin, as the largest organ of the human body, has the functions of preventing the loss of substances such as water, electrolytes and the like in the human body, preventing the invasion of external harmful substances, keeping the stability of the internal environment of the human body and the like, and is a common pursuit target of people for smooth, fine and elastic skin.
The aging of human body is the inevitable rule of life development, and the aging of skin around eyes is part of the aging of the body. Skin aging is caused by many factors, mainly internal and external factors. Internal factors include oxidation of molecules in skin cells, glycation of collagen, and reduction in hormone secretion levels, etc.; external factors are mainly ultraviolet rays and environmental pollution, and especially, ultraviolet rays have a great influence on skin aging.
The skin aging is manifested by increased beryllium streaks, loose skin, reduced elasticity and the like in appearance, and with the economic development and social progress, people pay more attention to the external image, and the delaying of the skin aging is expected by people and is also a hot spot for the research of anti-skin aging medicaments and health care products.
The skin of the eyes is the weakest place of the whole body and is also the place where the aging of the human body starts first. In life, people find that once the eyes of people begin to have problems such as eye wrinkles, eye drop, eye bags, dark circles and the like, the people look old. The thickness of the skin around the eyes is 0.04-0.06mm, which is about 1/3 mm of the thickness of the facial skin. The periocular skin is one of the thinnest human skin, blinks about 2-3 ten thousand times a day and mobilizes 14 groups of muscles around the eyes. The aging of the human body begins from the eyes first.
With the continuous improvement of the living standard of the substances, people pursue higher-quality life and pay more and more attention to the health of the skin, so that the quality requirement of the beauty and skin care products is higher and higher. However, the existing skin care products mostly contain chemical components, and the addition of Chinese herbal medicine components is less, so that various media are frequently used for skin injury caused by using the skin care products. Therefore, the safety of skin care products is greatly improved, and the safety and the effectiveness become the main direction of research and development of the skin care products. Some Chinese herbal medicines are natural substances, can better nourish and clean the skin in the skin nursing and maintaining process, have safety which cannot be possessed by chemical substances, and have unique functions, but the effect is not as remarkable as the chemical substances, so that the Chinese herbal medicines cannot be fully applied.
Disclosure of Invention
The invention aims to provide a periocular anti-aging traditional Chinese medicine skin care composition which has the advantages of safety and remarkable anti-aging effect.
The invention also aims to provide a preparation method of the anti-aging traditional Chinese medicine skin-care composition for the periphery of eyes so as to obtain the anti-aging traditional Chinese medicine skin-care composition for the periphery of eyes.
The technical problem to be solved by the invention is realized by adopting the following technical scheme.
On one hand, the embodiment of the application provides a periocular anti-aging traditional Chinese medicine skin care composition which comprises the following raw materials in parts by weight: 1.7-5.2 parts of traditional Chinese medicinal materials, 0.1-0.5 part of avocado extract, 0.1-0.3 part of glabrous greenbrier rhizome extract, 2-6 parts of humectant, 1-3 parts of anti-aging agent, 0.5-2 parts of antioxidant and 60-80 parts of water.
On the other hand, the embodiment of the application provides a preparation method of the periocular anti-aging traditional Chinese medicine skin care composition, which comprises the following steps:
mixing water and humectant, heating and stirring to obtain treated substance 1;
adding the rest raw materials into the treated product 1, heating and stirring under sealed condition to obtain the final product of the anti-aging traditional Chinese medicine skin care composition around eyes.
For the prior art, the embodiment of the invention has at least the following advantages or beneficial effects:
the traditional Chinese medicine composition is added with various traditional Chinese medicine extracts, can mildly maintain skin, has the effects of resisting oxidation and aging and eliminating black eyes, and has excellent effect due to the synergistic effect of various traditional Chinese medicine components; the glycyrrhiza glabra root extract can effectively inhibit tyrosinase activity, has a whitening effect, has a good inhibition effect on catalase, and reduces irritation to skin; in addition, it has certain anti-inflammatory effect. The avocado extract has good effect of inhibiting xanthine oxidase, has effect of scavenging superoxide radical generated by xanthine-xanthine oxidase system, and has skin activating and antiaging effects; the traditional Chinese medicinal materials can utilize effective components in natural medicinal materials, do not contain allergic components, are mild and non-irritant, have an outstanding anti-aging effect, and can effectively activate skin and reduce water loss; the humectant can lock moisture around eyes, so that moisture around eyes is prevented from being taken away by drying, and dry wrinkles around eyes are prevented; the anti-aging agent can be used for pertinently resisting aging and enabling epidermal cells to become plump; the antioxidant has antioxidant and antiaging effects.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present invention will be described in detail below with reference to specific examples.
The invention provides a periocular anti-aging traditional Chinese medicine skin care composition which comprises the following raw materials in parts by weight: 1.7-5.2 parts of traditional Chinese medicinal materials, 0.1-0.5 part of avocado extract, 0.1-0.3 part of glabrous greenbrier rhizome extract, 2-6 parts of humectant, 1-3 parts of anti-aging agent, 0.5-2 parts of antioxidant and 60-80 parts of water. The traditional Chinese medicine composition is added with various traditional Chinese medicine extracts, can mildly maintain skin, has the effects of resisting oxidation and aging and eliminating black eyes, and has excellent effect due to the synergistic effect of various traditional Chinese medicine components; the glycyrrhiza glabra root extract can effectively inhibit tyrosinase activity, has a whitening effect, has a good inhibition effect on catalase, and reduces irritation to skin; in addition, it has certain anti-inflammatory effect. The avocado extract has good effect of inhibiting xanthine oxidase, has effect of scavenging superoxide radical generated by xanthine-xanthine oxidase system, and has skin activating and antiaging effects; the traditional Chinese medicinal materials can utilize effective components in natural medicinal materials, do not contain allergic components, are mild and non-irritant, have an outstanding anti-aging effect, and can effectively activate skin and reduce water loss; the humectant can lock moisture around eyes, so that moisture around eyes is prevented from being taken away by drying, and dry wrinkles around eyes are prevented; the anti-aging agent can be used for pertinently resisting aging and enabling epidermal cells to become plump; the antioxidant has antioxidant and antiaging effects.
In some embodiments of the present invention, the anti-aging traditional Chinese medicine skin care composition for the periphery of the eye comprises the following raw materials: 3.8 parts of traditional Chinese medicine, 0.3 part of avocado extract, 0.2 part of glabrous greenbrier rhizome extract, 4 parts of humectant, 2 parts of anti-aging agent, 1.3 parts of antioxidant and 70 parts of water.
In some embodiments of the present invention, the traditional Chinese medicine extract comprises the following raw materials by weight: 0.3 to 1 portion of pseudo-ginseng extract, 0.6 to 1.5 portions of angelica extract, 0.1 to 0.5 portion of cassia seed extract, 0.1 to 0.5 portion of wild chrysanthemum extract, 0.2 to 0.5 portion of borneol, 0.1 to 0.4 portion of pearl powder, 0.1 to 0.3 portion of frankincense extract and 0.2 to 0.5 portion of oat extract. The Notoginseng radix extract has effects of promoting blood circulation for removing blood stasis, inhibiting edema, and resisting inflammation; it can eliminate oxygen free radicals, enhance activity of endogenous superoxide dismutase, enhance scavenging ability of organism to oxygen free radicals, relieve chain reaction caused by oxygen free radicals, and reduce lipid peroxidation in blood; it also has antibacterial effect, and contains Panax notoginsenosides, which can inhibit some fungi, Staphylococcus aureus and Escherichia coli. The angelica sinensis extract has certain effects of enriching blood and activating blood, and can improve skin microcirculation, remove dark circles and the like; it has the functions of promoting blood circulation and solidifying capillary blood vessel; the angelica has good SOD activity, can inhibit membrane lipid peroxidation and free radical reaction caused by superoxide radical, can resist damage of free radicals to tissues by combining with biological membrane phospholipid to protect membrane lipid and other mechanisms, and has special effects on dark complexion or sore swelling caused by free radical retardation; also has excellent anti-aging effect on the activation rate of the fluorescent enzyme and the proliferation effect on stem cells. The cassia seed extract has excellent eyesight improving and antioxidant effects, and has antioxidant effect. The flos Chrysanthemi Indici extract has effects of clearing liver-fire and improving eyesight, contains abundant nutritional components, has anti-inflammatory and antibacterial effects, and also has effects of clearing heat and detoxicating, and preventing skin aging. The Borneolum has effects of clearing heat, eliminating swelling and improving eyesight. The Margarita powder has effects of whitening skin, resisting aging, removing toxic substances, promoting granulation, and reducing facial speckle. The Olibanum extract has effect in promoting activation of caspase (caspase is core enzyme for apoptosis, and its inhibition means prolonging cell life), activating peroxidase to activate receptor, resisting aging, resisting inflammation, and preventing and treating red blood cell; meanwhile, the skin can be whitened and oily skin can be conditioned. The oat extract has the effects of nourishing skin, wherein the beta-glucan contained in the oat extract can promote the synthesis of collagen and eliminate free radicals, the beta-glucan contained in the oat extract can promote the proliferation of fibroblasts and the synthesis of collagen, has the free radical scavenging capacity and can resist the damage of ultraviolet rays, so that the effects of resisting aging, removing wrinkles, moisturizing the skin and the like are achieved.
In some embodiments of the present invention, the raw materials further comprise 0.1-0.3 parts by weight of an extract of ophiopogon root, 0.1-0.2 parts by weight of an extract of zingiber officinale root, and 0.2-0.4 parts by weight of an extract of purslane. The radix ophiopogonis extract is rich in active ingredients such as polyfructose, has good moisturizing capability, and can prevent excessive loss of skin moisture by strengthening adhesion of the upper layer of epidermis and recombining the barrier function of skin so as to achieve the moisturizing effect. The product has effects in improving skin activity, activating skin, resisting oxidation and resisting aging. The purslane contains alkaloid, coumarin compounds, flavonoid, phenols, mushrooms, sterol and other compounds, has antibacterial and anti-inflammatory effects, and has good oxygen radical scavenging capacity, which indicates that the purslane has obvious antioxidant effect; has good skin moisture keeping effect.
In some embodiments of the present invention, the humectant is at least one of glycerin, 1, 2-hexanediol, butylene glycol, acetyl hexapeptide-8, squalane, acetyl chitosamine, hydrolyzed elastin, and aloe vera leaf juice. The glycerin and the butanediol have good moisturizing performance, and the 1, 2-hexanediol also has the effects of sterilization and moisturizing. The acyl hexapeptide-8 can reduce existing facial wrinkles and effectively prevent new wrinkles, and can reduce contraction of muscles by inhibiting release of neurotransmitter acetylcholine, thereby achieving reduction of dynamic lines and expression lines, and in addition, has excellent moisturizing effect. Squalane has excellent moisturizing effect, and also has the characteristics of harmlessness, no irritation and low irritability. The acetyl chitosamine can accelerate wound healing, improve skin hydration degree, reduce skin fine lines and improve rough skin condition; can also inhibit the synthesis of tyrosinase, reduce the generation of melanin, improve uneven skin color, and has certain whitening and moisturizing effects. The aloe vera leaf juice has the effects of promoting the growth of fibrin, inhibiting elastin, promoting the synthesis of collagen and removing free radicals, and has good skin-activating and anti-aging effects; it also has a promoting effect on cholesterol synthesis, and helps to reduce shine and increase the degree of skin softness; it also has antibacterial, antiinflammatory and moisture keeping effects. The hydrolyzed elastin can supplement elastin content in aged skin, increase skin softness, and lubricate skin stratum corneum.
In some embodiments of the present invention, the anti-aging agent comprises (1-3): (1-3): 2:3: (1-2) palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly, and taurine. Palmitoyl pentapeptide-4 can stimulate the synthesis of collagen of a skin matrix to achieve the anti-aging effect, is composed of lysine, threonine and serine, penetrates into the skin through cream containing base peptide to reach fibroblasts, synthesizes small molecules of skin connective tissue in the fibroblasts, participates in the formation of the skin matrix, stimulates the synthesis of the collagen, and has the good effect of removing wrinkles. Carnosine can resist free radical damage, remove free radicals and achieve the effect of antioxidation; carnosine can also achieve the effect of delaying aging by protecting mitochondrial function and reducing the generation of ROS; can react with active substances in vivo to protect protein from glycosylation, and has anti-aging effect, and carnosine contains imidazole ring, has strong oxidation resistance, and can prevent fibroblast growth and reverse aged human cells. The royal jelly contains protein, lipid, saccharide, vitamins, amino acids and minerals, has effects of resisting aging, resisting tumor, resisting bacteria, regulating immunity and promoting cell proliferation, can give cell energy, recover cell activity, and help skin growth, and has certain therapeutic effect on seborrheic dermatitis and acne. Taurine is helpful for synthesis of cysteine in vivo, has effects of nourishing skin and enhancing activity of cortical cells, and has anti-aging effect and anti-inflammatory effect in combination with its anti-oxygen property.
In some embodiments of the invention, the antioxidant is at least two of ascorbyl palmitate, tocopherol, aescin, panthenol and laminaria saccharina extract. Ascorbyl palmitate is a fat-soluble antioxidant, retains the pharmacological actions of ascorbic acid, namely vitamin C, in resisting oxidation, preventing angiosclerosis and treating septicemia, has fat solubility, and increases the application range of the product. Tocopherol is a fat-soluble vitamin and is also an excellent antioxidant. The natural vitamin E is easy to be absorbed by skin, and can promote skin metabolism, prevent pigmentation, improve skin elasticity, moisten skin, and has effects of caring skin, caring skin and resisting aging. Aescin has anti-inflammatory and swelling relieving effects, and can protect arterial blood vessel and improve venous function, and has anti-inflammatory and antioxidant effects; also has effects in inhibiting collagenase, hyaluronidase, beta-glucuronidase and elastase which catalyze the breakdown of the integrity of the venous structure and increase the exudation of the capillaries; in external preparation, the composition has effects in promoting blood circulation, promoting wound healing, relieving edema, resisting inflammation, resisting exudation, and protecting blood vessel (removing dark eye circles, removing red blood streak, resisting wrinkle, and repairing). Panthenol molecules penetrate into the stratum corneum of the skin and are rapidly reduced to vitamin B5 by enzymes, keeping the skin tender. The laminaria saccharina extract has certain inhibition effect on the activity of elastase and the elimination effect on oxygen free radicals, so that the laminaria saccharina extract has the effects of preventing wrinkles and resisting aging; has effect in inhibiting uricase, and can reduce ammonia substances generated by uricase activity.
The preparation method of the periocular anti-aging traditional Chinese medicine skin care composition is characterized by comprising the following steps:
mixing water and humectant, heating and stirring to obtain treated substance 1;
adding the rest raw materials into the treated product 1, heating and stirring under sealed condition to obtain the final product of the anti-aging traditional Chinese medicine skin care composition around eyes. The preparation method is simple and convenient, and can be put into large-scale production.
In some embodiments of the present invention, the above-mentioned treatment 1 is heated at 65 to 75 ℃ for 20 to 30 min.
In some embodiments of the invention, the heating temperature of the finished product of the anti-aging traditional Chinese medicine skin care composition for the periphery of the eyes is 55-65 ℃, and the stirring time is 40-60 min.
The features and properties of the present invention are described in further detail below with reference to examples.
Example 1
A preparation method of a periocular anti-aging traditional Chinese medicine skin care composition comprises the following steps:
raw materials: 3g of pseudo-ginseng extract, 6g of Chinese angelica extract, 1g of cassia seed extract, 1g of wild chrysanthemum flower extract, 2g of borneol, 1g of pearl powder, 1g of frankincense extract, 2g of oat extract, 1g of avocado extract, 1g of glycyrrhiza glabra root extract, 20g of humectant (glycerin), 10g of anti-aging agent (palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly and taurine in a weight ratio of 1: 1: 2: 3: 1), 5g of antioxidant (ascorbyl palmitate and tocopherol) and 600g of water.
Mixing water and humectant, heating to 65 deg.C, and stirring for 20min to obtain treated substance 1;
adding the rest raw materials into the treated product 1, heating to 55 deg.C under sealed condition, and stirring for 40min to obtain the final product.
Example 2
A preparation method of a periocular anti-aging traditional Chinese medicine skin care composition comprises the following steps:
raw materials: 6g of pseudo-ginseng extract, 10g of Chinese angelica extract, 2g of cassia seed extract, 2g of wild chrysanthemum flower extract, 3g of borneol, 2g of pearl powder, 2g of frankincense extract, 3g of oat extract, 2g of avocado extract, 2g of glycyrrhiza glabra root extract, 35g of humectant (glycerin), 20g of anti-aging agent (palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly and taurine in a weight ratio of 2: 2: 2: 3: 2), 12g of antioxidant (ascorbyl palmitate and tocopherol) and 650g of water.
Mixing water and humectant, heating to 70 deg.C, and stirring for 25min to obtain treated product 1;
adding the rest raw materials into the treated product 1, heating to 60 deg.C under sealed condition, and stirring for 50min to obtain the final product.
Example 3
A preparation method of a periocular anti-aging traditional Chinese medicine skin care composition comprises the following steps:
raw materials: 8g of pseudo-ginseng extract, 13g of Chinese angelica extract, 3g of cassia seed extract, 4g of wild chrysanthemum flower extract, 4g of borneol, 3g of pearl powder, 2g of frankincense extract, 4g of oat extract, 3g of avocado extract, 2g of glabrous greenbrier rhizome extract, 45g of humectant (glycerin), 25g of anti-aging agent (palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly and taurine in a weight ratio of 3: 2: 2: 3: 2), 15g of antioxidant (ascorbyl palmitate and tocopherol) and 700g of water.
Mixing water and humectant, heating to 70 deg.C, and stirring for 25min to obtain treated product 1;
adding the rest raw materials into the treated product 1, heating to 60 deg.C under sealed condition, and stirring for 50min to obtain the final product.
Example 4
A preparation method of a periocular anti-aging traditional Chinese medicine skin care composition comprises the following steps:
raw materials: 10g of pseudo-ginseng extract, 15g of Chinese angelica extract, 5g of cassia seed extract, 5g of wild chrysanthemum flower extract, 5g of borneol, 4g of pearl powder, 3g of frankincense extract, 5g of oat extract, 5g of avocado extract, 3g of glycyrrhiza glabra root extract, 20-60g of humectant (glycerin), 30g of anti-aging agent (palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly and taurine in a weight ratio of 3: 3: 2: 3: 2), 20g of antioxidant (ascorbyl palmitate and tocopherol) and 800g of water.
Mixing water and humectant, heating to 75 deg.C, and stirring for 30min to obtain treated product 1;
adding the rest raw materials into the treated product 1, heating to 65 deg.C under sealed condition, and stirring for 60min to obtain the final product.
Example 5
A preparation method of a periocular anti-aging traditional Chinese medicine skin care composition comprises the following steps:
raw materials: 8g of pseudo-ginseng extract, 13g of Chinese angelica extract, 3g of cassia seed extract, 4g of wild chrysanthemum flower extract, 4g of borneol, 3g of pearl powder, 2g of frankincense extract, 4g of oat extract, 3g of avocado extract, 2g of glycyrrhiza glabra root extract, 45g of humectant (1, 2-hexanediol, butanediol and acetyl hexapeptide-8), 25g of anti-aging agent (palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly and taurine in a weight ratio of 3: 2: 2: 3: 2), 15g of antioxidant (ascorbyl palmitate and tocopherol) and 700g of water.
Mixing water and humectant, heating to 70 deg.C, and stirring for 25min to obtain treated product 1;
adding the rest raw materials into the treated product 1, heating to 60 deg.C under sealed condition, and stirring for 50min to obtain the final product.
Example 6
A preparation method of a periocular anti-aging traditional Chinese medicine skin care composition comprises the following steps:
raw materials: 8g of pseudo-ginseng extract, 13g of Chinese angelica extract, 3g of cassia seed extract, 4g of wild chrysanthemum flower extract, 4g of borneol, 3g of pearl powder, 2g of frankincense extract, 4g of oat extract, 3g of avocado extract, 2g of glycyrrhiza glabra root extract, 45g of moisturizer (glycerol, 1, 2-hexanediol, butanediol, acetyl hexapeptide-8, squalane, acetyl chitosamine, hydrolyzed elastin and aloe barbadensis leaf juice), 25g of anti-aging agent (palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly and taurine in a weight ratio of 3: 2: 2: 3: 2), 15g of antioxidant (ascorbyl palmitate, tocopherol, aescin, panthenol and a sugar kelp extract) and 700g of water.
Mixing water and humectant, heating to 70 deg.C, and stirring for 25min to obtain treated product 1;
adding the rest raw materials into the treated product 1, heating to 60 deg.C under sealed condition, and stirring for 50min to obtain the final product.
Comparative example 1
This comparative example differs from example 3 in that: no Chinese medicinal materials are added.
Examples of the experiments
The skin care compositions prepared in examples 1-6 and comparative example 1 were subjected to volunteer experiments. 140 volunteers aged 30-35 years and having dry skin and fine lines/wrinkles around the eyes were randomly selected and tested in groups of 20 persons, groups 1-7, to test the skin care compositions prepared in examples 1-6 and comparative example 1, respectively. The skin care composition is applied around eyes twice in the morning and at night.
No skin care products other than the skin care composition were used during the experiment, during which the same facial cleanser was used for cleaning.
Allergy testing was performed on individual volunteers. Specifically, the skin care group materials of the corresponding group are pasted on the ears of the volunteers, and the skin allergy condition is observed after the mixture is waited for 24 hours. Skin is normal, no redness/no erythema is not allergic; weak erythema/redness/papules as weak allergies; erythema, redness, swelling, papules are strongly allergic. The results are shown in Table 1.
TABLE 1
| Group of | Non-allergic/human | Weak allergy/human | Strong allergy/human |
| Group 1 | 20 | 0 | 0 |
| 2 groups of | 20 | 0 | 0 |
| Group 3 | 20 | 0 | 0 |
| 4 groups of | 20 | 0 | 0 |
| 5 groups of | 20 | 0 | 0 |
| 6 groups of | 20 | 0 | 0 |
| 7 groups of | 20 | 0 | 0 |
From table 1, it can be seen that the skin care compositions prepared herein are mild in nature, are not prone to human allergy, and can be tested on a continuous basis.
Measuring the skin moisture content and the skin fineness respectively in the first half hour and the second half hour before use, and calculating the average skin moisture improvement rate and the average skin fineness improvement rate of each group; and after 1 month of continuous use, the skin care composition was evaluated to calculate an average score, and the results are shown in table 2.
The skin moisture content increase rate (skin moisture content after half hour of use-skin moisture content before half hour of use)/100%
The skin fineness improvement rate (skin fineness after half hour-skin fineness before half hour)/100%
The using effect is moistening without greasiness, good ductility, good moisture retention, mildness and good anti-aging effect, and the score is 8-10; the using effect is more moist, less greasy, better ductility, better moisture retention, milder and good anti-aging effect, and the score is 4-7; the use effect is too oily, the ductility is better, the moisture retention is better, the stimulation is better, the anti-aging effect is poor, and the score is 0-3.
TABLE 2
| Group of | The skin water content is improved by 100 percent | The improvement rate of skin fineness is 100 percent | Evaluation score/score |
| Group 1 | 51.3 | 63.5 | 9.5 |
| 2 groups of | 53.8 | 67.8 | 9.5 |
| Group 3 | 57.2 | 71.9 | 9.5 |
| 4 groups of | 55.1 | 72.0 | 9.2 |
| 5 groups of | 58.1 | 73.5 | 9.6 |
| 6 groups of | 60.2 | 78.4 | 9.7 |
| 7 groups of | 12.3 | 10.8 | 5.9 |
Analyzing table 2, it can be seen that the effect of the groups 1-6 is good compared to the group 7, and the effect of the group 6 is best by careful comparison, which indicates that the skin care composition prepared in example 7 has the best moisturizing, fine enhancing effect and use experience on skin.
In conclusion, the traditional Chinese medicine composition is added with various traditional Chinese medicine extracts, can mildly maintain skin, has the effects of resisting oxidation and aging and eliminating black eyes, and has excellent effect due to the synergistic effect of various traditional Chinese medicine components; the glycyrrhiza glabra root extract can effectively inhibit tyrosinase activity, has a whitening effect, has a good inhibition effect on catalase, and reduces irritation to skin; in addition, it has certain anti-inflammatory effect. The avocado extract has good effect of inhibiting xanthine oxidase, has effect of scavenging superoxide radical generated by xanthine-xanthine oxidase system, and has skin activating and antiaging effects; the traditional Chinese medicinal materials can utilize effective components in natural medicinal materials, do not contain allergic components, are mild and non-irritant, have an outstanding anti-aging effect, and can effectively activate skin and reduce water loss; the humectant can lock moisture around eyes, so that moisture around eyes is prevented from being taken away by drying, and dry wrinkles around eyes are prevented; the anti-aging agent can be used for pertinently resisting aging and enabling epidermal cells to become plump; the antioxidant has antioxidant and antiaging effects.
The embodiments described above are some, but not all embodiments of the invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, belong to the present invention.
Claims (10)
1. The anti-aging traditional Chinese medicine skin care composition for the periphery of eyes is characterized by comprising the following raw materials in parts by weight: 1.7-5.2 parts of traditional Chinese medicinal materials, 0.1-0.5 part of avocado extract, 0.1-0.3 part of glabrous greenbrier rhizome extract, 2-6 parts of humectant, 1-3 parts of anti-aging agent, 0.5-2 parts of antioxidant and 60-80 parts of water.
2. The anti-aging traditional Chinese medicine skin-care composition for the periphery of the eyes as claimed in claim 1, wherein the anti-aging traditional Chinese medicine skin-care composition for the periphery of the eyes comprises the following raw materials in parts by weight: 3.8 parts of traditional Chinese medicine, 0.3 part of avocado extract, 0.2 part of glabrous greenbrier rhizome extract, 4 parts of humectant, 2 parts of anti-aging agent, 1.3 parts of antioxidant and 70 parts of water.
3. The periocular anti-aging traditional Chinese medicine skin care composition according to claim 1, wherein the traditional Chinese medicine comprises the following raw materials in parts by weight: 0.3 to 1 portion of pseudo-ginseng extract, 0.6 to 1.5 portions of angelica extract, 0.1 to 0.5 portion of cassia seed extract, 0.1 to 0.5 portion of wild chrysanthemum extract, 0.2 to 0.5 portion of borneol, 0.1 to 0.4 portion of pearl powder, 0.1 to 0.3 portion of frankincense extract and 0.2 to 0.5 portion of oat extract.
4. The periocular anti-aging traditional Chinese medicine skin-care composition according to claim 1, characterized in that the raw materials further comprise 0.1-0.3 part by weight of radix ophiopogonis extract, 0.1-0.2 part by weight of ginger root extract and 0.2-0.4 part by weight of purslane extract.
5. The periocular anti-aging traditional Chinese medicine skin care composition according to claim 1, wherein the humectant is at least one of glycerin, 1, 2-hexanediol, butanediol, acetyl hexapeptide-8, squalane, acetyl chitosamine, hydrolyzed elastin, and aloe barbadensis leaf juice.
6. The periocular anti-aging traditional Chinese medicine skin-care composition as claimed in claim 1, wherein the anti-aging agent comprises the following components in weight ratio of (1-3): (1-3): 2:3: (1-2) palmitoyl pentapeptide-4, carnosine, palmitoyl tripeptide-38, royal jelly, and taurine.
7. The periocular anti-aging traditional Chinese medicine skin-care composition as claimed in claim 1, wherein the antioxidant is at least two of ascorbyl palmitate, tocopherol, aescine, panthenol and laminaria saccharina extract.
8. The method for preparing the anti-aging traditional Chinese medicine skin care composition for the periocular period as claimed in any one of claims 1 to 7, which comprises the following steps:
mixing water and humectant, heating and stirring to obtain treated substance 1;
adding the rest raw materials into the treated product 1, heating and stirring under sealed condition to obtain the final product of the anti-aging traditional Chinese medicine skin care composition around eyes.
9. The method for preparing the anti-aging traditional Chinese medicine skin-care composition for the periocular period as claimed in claim 8, wherein the heating temperature of the treatment substance 1 is 65-75 ℃, and the stirring time is 20-30 min.
10. The method for preparing the anti-aging traditional Chinese medicine skin-care composition for the periphery of eyes as claimed in claim 8, wherein the heating temperature of the finished product of the anti-aging traditional Chinese medicine skin-care composition for the periphery of eyes is 55-65 ℃, and the stirring time is 40-60 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111453662.0A CN113908110A (en) | 2021-12-01 | 2021-12-01 | Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111453662.0A CN113908110A (en) | 2021-12-01 | 2021-12-01 | Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113908110A true CN113908110A (en) | 2022-01-11 |
Family
ID=79248420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111453662.0A Pending CN113908110A (en) | 2021-12-01 | 2021-12-01 | Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113908110A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105434284A (en) * | 2015-12-31 | 2016-03-30 | 天津达仁堂京万红药业有限公司 | Moisturizing and nourishing eye serum and preparation method thereof |
| CN106580798A (en) * | 2016-12-30 | 2017-04-26 | 广州科盈化妆品有限公司 | All-in-one eye cream and preparation method |
| US20180042840A1 (en) * | 2015-03-05 | 2018-02-15 | Lubrizol Advanced Materials, Inc. | Ferment extract of eupenicillium crustaceum and cosmetic use thereof |
| CN108815069A (en) * | 2018-06-28 | 2018-11-16 | 芜湖扬展新材料科技服务有限公司 | A kind of plant moisturizing elimination eye pouch and edema eye cream and preparation method thereof |
| CN109833221A (en) * | 2019-04-01 | 2019-06-04 | 合肥卡迪尔生物科技有限公司 | A kind of anti-ageing aging facial treatment milk of eye and preparation method thereof |
| CN110604718A (en) * | 2019-11-11 | 2019-12-24 | 奢脉国际化妆品(北京)有限公司 | Full-effect polypeptide eye essence and preparation method thereof |
| CN110960436A (en) * | 2019-10-25 | 2020-04-07 | 广东密尚生物科技有限公司 | Skin care composition, eye cream and preparation method thereof |
| CN111035588A (en) * | 2019-12-19 | 2020-04-21 | 天津达仁堂京万红药业有限公司 | Plant extract soothing eye cream and preparation method thereof |
| CN114246817A (en) * | 2022-01-19 | 2022-03-29 | 广东巴松那生物科技有限公司 | Wrinkle-removing composition and preparation method and application thereof |
-
2021
- 2021-12-01 CN CN202111453662.0A patent/CN113908110A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180042840A1 (en) * | 2015-03-05 | 2018-02-15 | Lubrizol Advanced Materials, Inc. | Ferment extract of eupenicillium crustaceum and cosmetic use thereof |
| CN105434284A (en) * | 2015-12-31 | 2016-03-30 | 天津达仁堂京万红药业有限公司 | Moisturizing and nourishing eye serum and preparation method thereof |
| CN106580798A (en) * | 2016-12-30 | 2017-04-26 | 广州科盈化妆品有限公司 | All-in-one eye cream and preparation method |
| CN108815069A (en) * | 2018-06-28 | 2018-11-16 | 芜湖扬展新材料科技服务有限公司 | A kind of plant moisturizing elimination eye pouch and edema eye cream and preparation method thereof |
| CN109833221A (en) * | 2019-04-01 | 2019-06-04 | 合肥卡迪尔生物科技有限公司 | A kind of anti-ageing aging facial treatment milk of eye and preparation method thereof |
| CN110960436A (en) * | 2019-10-25 | 2020-04-07 | 广东密尚生物科技有限公司 | Skin care composition, eye cream and preparation method thereof |
| CN110604718A (en) * | 2019-11-11 | 2019-12-24 | 奢脉国际化妆品(北京)有限公司 | Full-effect polypeptide eye essence and preparation method thereof |
| CN111035588A (en) * | 2019-12-19 | 2020-04-21 | 天津达仁堂京万红药业有限公司 | Plant extract soothing eye cream and preparation method thereof |
| CN114246817A (en) * | 2022-01-19 | 2022-03-29 | 广东巴松那生物科技有限公司 | Wrinkle-removing composition and preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 王建新, 中国纺织出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008139182A2 (en) | Skin care composition | |
| CN111973481A (en) | Blue ketone peptide repair essence and preparation method thereof | |
| CN112043661B (en) | Whitening aloe gel and preparation method thereof | |
| CN109044941B (en) | Skin firming, nourishing and moisturizing composition and preparation method and application thereof | |
| CN113018238A (en) | Anti-bacterial, anti-inflammatory, refreshing and skin-benefiting acne-removing gel and preparation method thereof | |
| CN106511211B (en) | Anti-inflammatory acne-removing skin-care lotion and preparation method thereof | |
| CN106333880B (en) | toner based on thin emulsion and preparation method thereof | |
| CN111529450A (en) | Deep moisturizing repair composition, skin care product and preparation method thereof | |
| CN111973486A (en) | Ceramide moisturizing and moisture-keeping cream and preparation method thereof | |
| CN111973501A (en) | Ceramide activation milk and preparation method thereof | |
| KR101168796B1 (en) | Skin care cosmetic composition | |
| CN113730272A (en) | Eye protection patch with efficacy of relieving eye fatigue and preparation method thereof | |
| CN116459169B (en) | Anti-inflammatory moisturizing skin external composition and preparation method and application thereof | |
| CN113171324A (en) | Smooth apple-flesh mask and preparation method thereof | |
| CN112370404B (en) | Moisturizing and whitening composition, and preparation method and application thereof | |
| CN115282105A (en) | Infant Tong Hufu composition and preparation method thereof | |
| CN113908110A (en) | Anti-aging traditional Chinese medicine skin care composition for periocular period and preparation method thereof | |
| CN112057386A (en) | Refreshing, moisturizing, whitening and repairing sun block and preparation method thereof | |
| CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof | |
| CN109431824B (en) | Antibacterial deodorizing gel and application thereof | |
| CN110934785A (en) | Whitening and moisturizing facial cleanser for sensitive skin and preparation method thereof | |
| CN113368026B (en) | Moisturizing anti-wrinkle nourishing skin care gel and preparation method thereof | |
| KR102506318B1 (en) | A method of manufacturing seborrheic scalp inflammation and hair loss relief shampoo and seborrheic scalp inflammation and hair loss relief shampoo prepared thereby | |
| CN115804748A (en) | Whitening, acne-removing, moisturizing and repairing mask liquid containing multiple natural plant components, preparation method of mask liquid and mask | |
| CN113633603A (en) | Plant beautifying stock solution and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220111 |
|
| RJ01 | Rejection of invention patent application after publication |